242 related articles for article (PubMed ID: 21479203)
21. Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells.
Vangamudi B; Zhu S; Soutto M; Belkhiri A; El-Rifai W
Mol Cancer; 2011 Mar; 10():32. PubMed ID: 21447180
[TBL] [Abstract][Full Text] [Related]
22. PTEN is a protein phosphatase that targets active PTK6 and inhibits PTK6 oncogenic signaling in prostate cancer.
Wozniak DJ; Kajdacsy-Balla A; Macias V; Ball-Kell S; Zenner ML; Bie W; Tyner AL
Nat Commun; 2017 Nov; 8(1):1508. PubMed ID: 29142193
[TBL] [Abstract][Full Text] [Related]
23. Modulation of beta-catenin-mediated TCF-signalling in prostate cancer cell lines by wild-type and mutant p53.
Prowald A; Cronauer MV; von Klot C; Eilers T; Rinnab L; Herrmann T; Spindler KD; Montenarh M; Jonas U; Burchardt M
Prostate; 2007 Dec; 67(16):1751-60. PubMed ID: 17929268
[TBL] [Abstract][Full Text] [Related]
24. Mixed lineage kinase 3 modulates β-catenin signaling in cancer cells.
Thylur RP; Senthivinayagam S; Campbell EM; Rangasamy V; Thorenoor N; Sondarva G; Mehrotra S; Mishra P; Zook E; Le PT; Rana A; Rana B
J Biol Chem; 2011 Oct; 286(43):37470-82. PubMed ID: 21880738
[TBL] [Abstract][Full Text] [Related]
25. PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4.
Kwon IK; Wang R; Thangaraju M; Shuang H; Liu K; Dashwood R; Dulin N; Ganapathy V; Browning DD
Oncogene; 2010 Jun; 29(23):3423-34. PubMed ID: 20348951
[TBL] [Abstract][Full Text] [Related]
26. Targeting protein tyrosine kinase 6 enhances apoptosis of colon cancer cells following DNA damage.
Gierut JJ; Mathur PS; Bie W; Han J; Tyner AL
Mol Cancer Ther; 2012 Nov; 11(11):2311-20. PubMed ID: 22989419
[TBL] [Abstract][Full Text] [Related]
27. Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK.
Brauer PM; Tyner AL
Biochim Biophys Acta; 2010 Aug; 1806(1):66-73. PubMed ID: 20193745
[TBL] [Abstract][Full Text] [Related]
28. PSPC1-interchanged interactions with PTK6 and β-catenin synergize oncogenic subcellular translocations and tumor progression.
Lang YD; Chen HY; Ho CM; Shih JH; Hsu EC; Shen R; Lee YC; Chen JW; Wu CY; Yeh HW; Chen RH; Jou YS
Nat Commun; 2019 Dec; 10(1):5716. PubMed ID: 31844057
[TBL] [Abstract][Full Text] [Related]
29. Small molecule inhibitors reveal PTK6 kinase is not an oncogenic driver in breast cancers.
Qiu L; Levine K; Gajiwala KS; Cronin CN; Nagata A; Johnson E; Kraus M; Tatlock J; Kania R; Foley T; Sun S
PLoS One; 2018; 13(6):e0198374. PubMed ID: 29879184
[TBL] [Abstract][Full Text] [Related]
30. Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia.
Mizuguchi Y; Specht S; Isse K; Sasatomi E; Lunz JG; Takizawa T; Demetris AJ
J Hepatol; 2015 Aug; 63(2):399-407. PubMed ID: 25770659
[TBL] [Abstract][Full Text] [Related]
31. Embelin-Induced Apoptosis of Human Prostate Cancer Cells Is Mediated through Modulation of Akt and β-Catenin Signaling.
Park N; Baek HS; Chun YJ
PLoS One; 2015; 10(8):e0134760. PubMed ID: 26252009
[TBL] [Abstract][Full Text] [Related]
32. The intestine-specific transcription factor Cdx2 inhibits beta-catenin/TCF transcriptional activity by disrupting the beta-catenin-TCF protein complex.
Guo RJ; Funakoshi S; Lee HH; Kong J; Lynch JP
Carcinogenesis; 2010 Feb; 31(2):159-66. PubMed ID: 19734199
[TBL] [Abstract][Full Text] [Related]
33. Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator.
Wang S; Bao Z; Liang QM; Long JW; Xiao ZS; Jiang ZJ; Liu B; Yang J; Long ZX
Hepatogastroenterology; 2013 Oct; 60(127):1639-46. PubMed ID: 24634935
[TBL] [Abstract][Full Text] [Related]
34. PTK6 Localized at the Plasma Membrane Promotes Cell Proliferation and MigratiOn Through Phosphorylation of Eps8.
Shin WS; Shim HJ; Lee YH; Pyo M; Park JS; Ahn SY; Lee ST
J Cell Biochem; 2017 Sep; 118(9):2887-2895. PubMed ID: 28214294
[TBL] [Abstract][Full Text] [Related]
35. TNFα/IFNγ Mediated Intestinal Epithelial Barrier Dysfunction Is Attenuated by MicroRNA-93 Downregulation of PTK6 in Mouse Colonic Epithelial Cells.
Haines RJ; Beard RS; Eitner RA; Chen L; Wu MH
PLoS One; 2016; 11(4):e0154351. PubMed ID: 27119373
[TBL] [Abstract][Full Text] [Related]
36. Caveolin-1-mediated suppression of cyclooxygenase-2 via a beta-catenin-Tcf/Lef-dependent transcriptional mechanism reduced prostaglandin E2 production and survivin expression.
Rodriguez DA; Tapia JC; Fernandez JG; Torres VA; Muñoz N; Galleguillos D; Leyton L; Quest AF
Mol Biol Cell; 2009 Apr; 20(8):2297-310. PubMed ID: 19244345
[TBL] [Abstract][Full Text] [Related]
37. β-catenin is constitutively active and increases STAT3 expression/activation in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Anand M; Lai R; Gelebart P
Haematologica; 2011 Feb; 96(2):253-61. PubMed ID: 20971814
[TBL] [Abstract][Full Text] [Related]
38. Protein tyrosine kinase 6 regulates activation of SRC kinase.
Alwanian WM; Vlajic K; Bie W; Kajdacsy-Balla A; Tyner AL
J Biol Chem; 2022 Nov; 298(11):102584. PubMed ID: 36228719
[TBL] [Abstract][Full Text] [Related]
39. Sox17 and Sox4 differentially regulate beta-catenin/T-cell factor activity and proliferation of colon carcinoma cells.
Sinner D; Kordich JJ; Spence JR; Opoka R; Rankin S; Lin SC; Jonatan D; Zorn AM; Wells JM
Mol Cell Biol; 2007 Nov; 27(22):7802-15. PubMed ID: 17875931
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia leads to significant changes in alternative splicing and elevated expression of CLK splice factor kinases in PC3 prostate cancer cells.
Bowler E; Porazinski S; Uzor S; Thibault P; Durand M; Lapointe E; Rouschop KMA; Hancock J; Wilson I; Ladomery M
BMC Cancer; 2018 Apr; 18(1):355. PubMed ID: 29606096
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
